Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER-VITAL: Paxlovid for Long COVID
NCT05965726Phase 2Completed
- Sponsor
- Kanecia Obie Zimmerman
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Nirmatrelvir in post-COVID-19 condition (PCC), sponsored by Kanecia Obie Zimmerman. Started Jul 2023; status: completed.
02
Drugs
Nirmatrelvir
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05965726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05965726.